DiviDrip · BRTX

BRTX — BioRestorative Therapies, Inc.

BRTX is BioRestorative Therapies, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.20. Market cap: $5M. Capital Quality Rank: 31/100 — Stagnant mediocrity.

Stock snapshot

Price$0.20
Market cap$5M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)31 / 100 · Stagnant mediocrity
Revenue CAGR (3y)44.3%
Shareholder buyback yield-13.67%
Altman Z-score zoneDistress

About BRTX

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

Listed1997Employees14HQMelville, NYSectorHealthcareWebsitebiorestorative.com

Related non-dividend companies

Other non-dividend stocks investors research alongside BRTX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is BRTX's current stock price?

BRTX (BioRestorative Therapies, Inc.) is currently trading at $0.20.

Does BRTX pay a dividend?

BRTX (BioRestorative Therapies, Inc.) does not currently pay a regular dividend.

What is BRTX's Capital Quality Rank?

BRTX has a Capital Quality Rank of 31/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track BRTX in DiviDrip

Add BRTX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow